Behind the Scenes of Eli Lilly's Latest Options Trends
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Spetz Announces Extension Convertible Debenture and Updates
Spetz Announces Results for the Three and Nine Months Ended September 30, 2024
Wednesday Ends With Index Decline | Wall Street Today
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
'Bunker' and 'Booster' Stocks in the U.S. – Which Would Perform Better in a Downturn Vs. Upturn?
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
UnitedHealth Group Analyst Ratings
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Sarepta Therapeutics Analyst Ratings
Tradepulse Power Inflow Alert: Eli Lilly & Company Climbs Over 22 Points After Alert
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Amgen's weight loss drug has a remarkable 20% reduction effect, but with high side effects, causing the stock price to plummet by 12.3% at one point!
Although the weight loss effect of amgen's MariTide drug met expectations, the high side effects, lower than eli lilly and co's Zepbound, and the trial results falling below Wall Street's high expectations, led to amgen's stock price plunging over 12.3% on Tuesday, far behind eli lilly and co and novo-nordisk a/s, which benefited from the Biden policy rise at the same time. In a one-year trial, MariTide helped non-diabetic patients lose up to 20% of their weight, comparable to the maximum dose effect of eli lilly's Zepbound. However, the side effects are significant, with about 11% of patients dropping out of the trial due to side effects, higher than eli lilly's 7%.
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
Unpacking the Latest Options Trading Trends in Intuitive Surgical
Bird Flu Found In Raw Milk Leads To Recall In California
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs